Babar, Z. and Babar, A. 2025. Aprocetentin (Tryvio): A breakthrough in treating Resistant Hypertension. Journal of the Pakistan Medical Association. 75, 12 (Nov. 2025), 1996–1997. DOI:https://doi.org/10.47391/JPMA.25-21330.